Gene-Therapy Company Crispr Drops as FDA Puts Trial on Hold | oneSCDvoice
  • Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials
learn more
view full news & events section

Gene-Therapy Company Crispr Drops as FDA Puts Trial on Hold


Crispr Therapeutics AG plunged after the gene-editing company said a planned trial of its treatment to help people with sickle-cell disease was being put on hold by U.S. regulators.

Crispr is developing the therapy with Vertex Pharmaceuticals Inc., and the trial had yet to begin. The companies said in a statement Wednesday that the Food and Drug Administration placed a halt on the experiment until the agency could get more information from the companies.

https://www.onescdvoice.com/wp-content/uploads/2018/06/bloomberg.comnewsarticles.jpg

expertly curated content related to this topic